Cyclin E overexpression in human gallbladder carcinomas

Oncology Reports

Volumn 6, Issue 1, 1999, Pages 93-96

  Eguchi, Noriaki ^a   Fujii, Kiyomu ^a   Tsuchida, Akira ^a   Yamamoto, Shigeru ^a   Sasaki, Tamito ^a   Kajiyama, Goro ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Cyclin E; Gallbladder carcinoma; Immunohistochemical study

Indexed keywords

BIOLOGICAL MARKER; CYCLIN E; CYCLINE; TUMOR PROTEIN;

ARTICLE; CARCINOMA; CELL CYCLE; CELL DIVISION; CHEMISTRY; DISEASE COURSE; GALLBLADDER TUMOR; HUMAN; PATHOLOGY; WESTERN BLOTTING;

BIOLOGICAL MARKERS; BLOTTING, WESTERN; CARCINOMA; CELL CYCLE; CELL DIVISION; CYCLIN E; DISEASE PROGRESSION; GALLBLADDER NEOPLASMS; HUMANS; NEOPLASM PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0032622214     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.6.1.93     Document Type: Article

References (26)

1. Hunter T and Pines J: Cyclins and cancer II: cyclin D and cdk inhibitors come of age. Cell 79: 573-582, 1994.
2. Sherr C J: Mammalian GI cyclins. Cell 79: 1059-1065, 1993.
3. Heichman KA and Roberts JM: Rules to replicate by. Cell 79: 557-562, 1994.
4. Kitahara K, Yasui W, Kuniyasu H, Yokozaki H, Akama Y, Yunotani S, Hisatsugu T and Tahara E: Concurrent amplification of cyclin E and cdk2 genes in colorectal carcinomas. Int J Cancer 62: 25-28, 1995.
5. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, Shibagaki I, Nakao K, Ikenaga M and Ishizaki K: Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 54: 3107-3110, 1994.
6. Burkley MF, Sweeny KJE, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CKW, Musgrove EA and Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133, 1993.
7. Akama Y, Yasui W, Yokozaki H, Kuniyasu H, Kitahara K, Ishikawa T and Tahara E: Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn J Cancer Res 86: 617-621, 1995.
8. cdc2 and its kinase activity in human gastric and colonic carcinomas. Int J Cancer 43: 36-41, 1993.
9. Yasui W, Akama Y, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F and Tahara E: Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status. J Exp Ther Oncol 1: 88-94, 1996.
10. Yasui W, Kuniyasu H, Yokozaki H, Semba S, Shimamoto F and Tahara E: Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein. Virchows Arch 429: 13-19, 1996.
11. Albores-Saavedra J, Henson DE and Sobin LH: Histological typing of tumors of the gallbladder carcinoma and extrahepatic bile ducts. In: WHO International Histological Typing of Tumors. Springer, Berlin. 1992.
12. Fujii K, Yasui W, Shimamoto F, Yokozaki H, Nakayama H, Kajiyama G and Tahara E: Immunohistochemical analysis of nm23 gene product in human gallbladder carcinomas. Virchows Arch 426: 355-359, 1995.
13. Fujii K, Yasui W, Kuniyasu H, Itoh M, Hanada K, Kajiyama G and Tahara E: Expression of cripto in human gallbladder lesions. J Pathol 180: 166-168, 1996.
14. Beahrs OH, Henson DE and Hutter RVP (eds): Manual for Staging of Cancer. 4th edition. JB Lippincott, Philadelphia, 1992.
15. Hanada K, Itoh M, Fujii K, Tsuchida A, Ishimaru S, Hirata M and Kajiyama G: Expression of the proliferative cell nuclear antigen (PCNA) in adenocarcinoma of the gallbladder, and its relationship to prognosis. Scand J Clin Lab Invest 55: 377-382, 1995.
16. ERBB2 expression and the gene amplification. Cancer Res 50: 8002-8009, 1990.
17. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert H J and Pardee AB: Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54: 380-385, 1994.
18. Keyomarsi K and Pardee AB: Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90: 1112-1116, 1993.
19. Dou QP: Cyclin E - a better prognostic marker for breast cancer than cyclin D? Nat Med 2: 254, 1996.
20. Fujii K, Yokozaki H, Yasui W, Kuniyasu H, Hirata M, Kajiyama G and Tahara E: High frequency of p53 gene mutation in adenocarcinomas of the gallbladder. Cancer Epidemiol Biomarkers Prev 5: 461-466, 1996.
21. Oohashi Y, Watanabe H, Ajioka Y and Hatakeyama K: p53 immunostaining distinguishes malignant from benign lesions of the gallbladder. Pathol Int 45: 58-65, 1995.
22. Takagi S, Naito E, Yamauchi H, Ohtsuka H, Kominami R and Yamamoto M: Mutation of the p53 gene in gallbladder cancer. Tohoku J Exp Med 172: 283-289, 1994.
23. Teh M, Wee A, Path MRC and Raju GC: An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ ampullary carcinomas. Cancer 74: 1542-1545, 1994.
24. Hollstein MC, Metcalf RA, Welsh JA, Montesano R and Harris CC: Frequent mutation of p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 87: 9958-9961, 1990.
25. Woods AL, Hall PA, Shepherd NA, Hanby AM, Waseem NH, Lane DP and Levison DA: The assessment of proliferating cell nuclear antigen immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase (flow cytometric analysis) fraction and prognosis. Histopathology 19: 21-27, 1991.
26. Theunissen PHMH, Leers MPG and Bollen ECM: Proliferative cell nuclear antigen (PCNA) expression in formalin-fixed tissue of non-small cell lung carcinoma. Histopathology 20: 251-255, 1992.